Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland · Delayed Price · Currency is CHF 100.60
-0.40 (-0.40%)
At close: Dec 19, 2025
Cosmo Pharmaceuticals Market Cap
Cosmo Pharmaceuticals has a market cap or net worth of 1.6 billion as of December 19, 2025. Its market cap has increased by 60.66% in one year.
Market Cap
1.60B
Enterprise Value
1.49B
Revenue
170.24M
Ranking
n/a
PE Ratio
29.36
Stock Price
100.60
Market Cap Chart
Since March 12, 2007, Cosmo Pharmaceuticals's market cap has increased from 194.90M to 1.60B, an increase of 722.70%. That is a compound annual growth rate of 11.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.60B | 56.88% |
| Dec 30, 2024 | 1.02B | 24.91% |
| Dec 29, 2023 | 818.27M | -18.39% |
| Dec 30, 2022 | 1.00B | -9.22% |
| Dec 30, 2021 | 1.10B | -10.15% |
| Dec 30, 2020 | 1.23B | 9.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 278.18B |
| Novartis AG | 208.23B |
| Galderma Group AG | 38.65B |
| Lonza Group AG | 37.42B |
| Alcon | 31.21B |
| Sandoz Group AG | 25.02B |
| Straumann Holding AG | 15.03B |
| Sonova Holding AG | 12.29B |